Press releases
- Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
- Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders
- Gabather reports initial positive results from the EEG/fMRI target engagement study
Key statistics
As of last trade, Gabather AB (GABA:STO) traded at 1.59, 100.13% above the 52 week low of 0.792 set on Feb 29, 2024.
52-week range
Open | 1.59 |
---|---|
High | 1.59 |
Low | 1.59 |
Bid | 1.50 |
Offer | 1.59 |
Previous close | 1.60 |
Average volume | 63.60k |
---|---|
Shares outstanding | 18.10m |
Free float | 17.30m |
P/E (TTM) | -- |
Market cap | 28.86m SEK |
EPS (TTM) | -0.652 SEK |
Data delayed at least 15 minutes, as of Apr 19 2024 08:49 BST.
More ▼